Delivery Order SPE2DR25D3005-SPE2DR26FP7GE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a $2,739.35 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This is a firm fixed price contract with an ultimate completion date of November 14, 2025, and represents a small-value delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract was awarded non-competitively through this existing indefinite delivery contract,...
- The Defense Logistics Agency awarded a $5,213.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $40,702.19. The award, issued on November 14, 2025, is a firm fixed price delivery order with an ultimate completion date of November 17, 2025. This contract represents a non-competitive set-aside award, indicating the vendor was selected through open competition to supply this specialized pharmaceutical product. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $2,321.19 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric iron supplement procurement supporting federal medical supply requirements. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. This is a competitively awarded, firm fixed-price contract with no set-aside designation and a ceiling value of $11,438.76. The delivery order is scheduled for completion by October 31, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $24,546.62 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 8, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7GEDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on November 17, 2025, valued at $1,307.90 for the supply of Ferumoxytol 510 mg/17 ml vials. This contract is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency under a competitive process with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide. Ferumoxytol is an iron replacement therapy used for treating iron deficiency anemia in patients with chronic kidney disease. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of specialty medications, brand-name and generic drugs, and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's competitively awarded contracts demonstrate its capability to fulfill diverse federal medical supply requirements ranging from routine commodities to specialized pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/17/25 |